The future of inflammatory bowel disease care. [electronic resource]
Producer: 20100304Description: E69-77 p. digitalISSN:- 1949-4386
- Adalimumab
- Adrenal Cortex Hormones -- therapeutic use
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Azathioprine -- therapeutic use
- Certolizumab Pegol
- Clinical Trials as Topic
- Gastrointestinal Agents -- therapeutic use
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Inflammatory Bowel Diseases -- drug therapy
- Infliximab
- Mercaptopurine -- therapeutic use
- Mesalamine -- therapeutic use
- Natalizumab
- Polyethylene Glycols -- therapeutic use
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.